the data provide evidence that pcp at the doses tested alters dopaminergic neurotransmission in a manner different from that of amphetamine and the non-amphetamine central nervous system stimulants by decreasing da release from dopaminergic nerve terminals .
C0013030
da
C0282151
dopaminergic